Let's say P matches Otezla and for some crazy reasons no BP is interested so Leo is forced to advance it alone. I'll also assume one Phase 3 cost $15M (maximum) and the SP is $2 (minimum) after positive result is announced. So it'll take 7.5M shares (5.7% dilution) from the $42.8M shelf registration. Problems?
Dilutions are part of the game and it takes money to make money. So what was your concern again?
Quote:Either of these would be north of $30M IMO.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links